![](/img/cover-not-exists.png)
Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis
Liu, Qiao, Luo, Xia, Peng, Liubao, Yi, Lidan, Wan, Xiaomin, Zeng, Xiaohui, Tan, ChongqingLanguage:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-019-00869-3
Date:
November, 2019
File:
PDF, 881 KB
english, 2019